IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways

Sung Yeoun Hwang1, Ju‐Young Kim1, Kyoung-Woon Kim1, Mi-Kyung Park1, Young Myoung Moon1, Wan‐Uk Kim2, Ho-Youn Kim2
1Rheumatism Research Center, Catholic Institutes of Medical Science, The Catholic University of Korea, Seoul, Korea
2Center for Rheumatic Diseases, Kangnam St Mary's Hospital, The Catholic University of Korea Medical School, Seoul, Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

Miossec P: Interleukin-17 in rheumatoid arthritis. Arthritis Rheum. 2003, 48: 594-601. 10.1002/art.10816.

Cai L, Yin J, Starovasnik M, Hogue D, Hillan K, Mort J, Filvarorff E: Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine. 2001, 16: 10-21. 10.1006/cyto.2001.0939.

Bush K, Walker J, Lee C, Kirham B: Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: Interleukin-17 expression is upregulated in early disease. Clin Exp Immunol. 2001, 123: 487-495. 10.1046/j.1365-2249.2001.01469.x.

Kehlen A, Thiele K, Riemann D, Langer J: Expression, modulation and signaling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin Exp Immunol. 2002, 127: 539-546. 10.1046/j.1365-2249.2002.01782.x.

Katz Y, Nadiv O, Beer Y: Interleukin-17 enhances tumor necrosis factor α induced synthesis of interleukins 1, 6, and 8 in skin and synovial fibroblasts. Arthritis Rheum. 2001, 44: 2176-2184. 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4.

Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, De Benedetti F, Poli V, Ciliberto G: Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med. 1998, 187: 461-468. 10.1084/jem.187.4.461.

Joosten L, Lubberts E, Helsen M, Saxne T, Cornen-de Roo C, Heinegard D, van den Berg WB: Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res. 1999, 1: 81-91. 10.1186/ar14.

Lubberts E, Joosten L, Oppers B, van den Bersselaar L, Coenen-de Roo C, Kolls J, Schwarzenberger P, van de Loo F, van den Berg W: IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol. 2001, 167: 1004-1013.

Chabaud M, Lubberts E, Joosten L, van den Berg W, Miossec P: IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 2001, 3: 168-177. 10.1186/ar294.

Subramaniam S, Cooper R, Adunyah S: Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. Biochem Biophys Res Commun. 1999, 262: 14-19. 10.1006/bbrc.1999.1156.

Schwandner R, Yamaguchi K, Cao Z: Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med. 2000, 191: 1233-1239. 10.1084/jem.191.7.1233.

Handel M, McMorrow L, Gravallese E: Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum. 1995, 38: 1762-1770.

Marok R, Winyard P, Coumbe A, Kus M, Blades S, Mapp P, Morris C, Blake D, Kaltschmidt C, Baeuerle P: Activation of the transcription factor nuclear factor-kappa B in human inflamed synovial tissue. Arthritis Rheum. 1996, 39: 583-591.

Georganas C, Liu H, Perlman H, Hoffmana A, Thimmapaya B, Pope R: Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-κB but not C/EBPβ or c-Jun. J Immunol. 2000, 165: 7199-7206.

Ziolkowska M, Koe A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W: High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporine A-sensitive mechanism. J Immunol. 2000, 164: 2832-2838.

Chabaud M, Durand J, Buchs N, Fossiez F, Page G, Frappart L, Miossec P: Human interleukin 17; a T cell-derived proinflammatory cytokine produced by the rheumatoid arthritis synovium. Arthritis Rheum. 1999, 42: 963-970. 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E.

Cho ML, Yoon CH, Hwang SY, Park MK, Min SY, Lee SH, Park SH, Kim HY: Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients. Arthritis Rheum.

Scuderi E, Convertino R, Molino N, Provenzano C, Marino M, Zoli A, Bartoccioni E: Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus. Autoimmunity. 2003, 36: 71-77. 10.1080/0891693031000079275.

Woltman A, de Haji S, Boonstra J, Gobin S, Daha M, vab Kooten C: Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol. 2000, 11: 2044-2055.

Hata K, Andoh A, Shimada M, Fujino S, Bamba S, Araki Y, Okuno T, Fujiyama Y, Bamba T: IL-17 stimulates inflammatory responses via NF-κB and MAP kinase pathway in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 2002, 282: G1035-G1044.

Kim G, Jun J, Elkon K: Necessary role of phosphatidylinositol 3-kinase in transforming growth factor β-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2002, 46: 1504-1511. 10.1002/art.10314.

Aidinis V, Plows D, Haralambous S, Armaka M, Papadopoulos P, Kanaki M, Koczan D, Thiesen J, Kollias G: Functional analysis of an arthritogenic synovial fibroblast. Arthritis Res Ther. 2003, 5: R140-R157. 10.1186/ar749.

Yamamura Y, Gupta R, Morita Y, He X, Pai R, Endres J, Freiberg A, Chung K, Fox D: Effector function of resting T cells: activation of synovial fibroblasts. J Immunol. 2001, 166: 2270-2275.

Chabaud M, Fossiez F, Taupin J-L, Miossec P: Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol. 1998, 161: 409-414.

Aggarwal S, Gurney A: IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002, 71: 1-8.

Shi Y, Ullrich S, Zhang J, Connolly K, Grzegorzewski K, Barber M, Wang W, Wathen K, Hodge V, Fisher C, Olsen H, Ruben S, Knyazev I, Cho Y-H, Kao V, Wilkinson K, Carrell J, Ebner R: A novel cytokine receptor-ligand pair. J Biol Chem. 2000, 275: 19167-19176. 10.1074/jbc.M910228199.

Lee J, Ho W-H, Maruoka M, Corpuz R, Baldwin D, Foster J, Goddard A, Yansura D, Vandlen R, Wood W, Gurney A: IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem. 2001, 276: 1660-1664. 10.1074/jbc.M008289200.

Kehlen A, Pachnio A, Thiele K, Langner J: Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6. Arthritis Res Ther. 2003, 5: R186-R192. 10.1186/ar762.

Shimada M, Andoh A, Hata K, Tasaki K, Araki Y, Fusiyama Y, Bamba T: IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J Immunol. 2002, 168: 861-868.

Hsu YM, Lucci J, Su L, Ehrenfels B, Garber E, Thomas D: Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes. J Biol Chem. 1997, 272: 911-915. 10.1074/jbc.272.2.911.

Pietravalle F, Lecoanet-Henchoz S, Blasey H, Aubry JP, Elson G, Edgerton MD, Bonnefoy JY, Gauchat JF: Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J Biol Chem. 1996, 271: 5965-5967. 10.1074/jbc.271.11.5965.

Morel J, Park C, Woods J, Koch A: A novel role for interleukin-18 in adhesion molecule induction through NFκB and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J Biol Chem. 2001, 276: 37069-37075. 10.1074/jbc.M103574200.

Ozes O, Mayo L, Gustin J, Pfeffer S, Pfeffer L, Donner D: NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature. 1999, 401: 82-85. 10.1038/43466.